Cancer
Credibility 80
First-line treatment patterns and real-world survival outcomes in PD-L1-negative locally recurrent inoperable or metastatic triple-negative breast cancer in the United States.
August 5, 2026 · Breast cancer research and treatment
Key takeaway
For Black women with an aggressive breast cancer called triple-negative, this study found current treatments don't work well, and survival rates are low. This means we urgently need better, more effective treatments for our community.
Why this matters for our communities
Research in cancer helps close long-standing gaps in how Black and African American families are studied, diagnosed, and cared for. Use findings like this one to start informed conversations with your care team — not as a substitute for personal medical advice.
More in Cancer
February 1, 2027Dual-modal immunoassay for prostate cancer-derived exosomes enabled by a black phosphorus/silver SERS substrate and Yb/Er co-doped NaGdF4 UCL nanoprobes.Read December 18, 2026Factors Associated with Screening Mammography Utilization Among Women Veterans in VA Primary Care.Read November 16, 2026Characterizing prior symptomatic emergency department visits among patients undergoing unplanned colon cancer surgery.Read